Perinatal Biologics Supplier for Medspas and Dermatology in Tallahassee, FL

Vendor review for medspas operating under physician supervision

Medspas that operate under a supervising physician typically route a new biologics vendor through that physician or medical director before any product reaches a treatment room, confirming the supplier's documentation matches what the medical director is willing to put their license behind.

Dermatology and plastic surgery practices considering a Wharton's jelly or exosome product generally request the certificate of analysis, donor eligibility summary and, for exosome formats, available particle characterization or ingredient disclosure before a product is added to inventory.

Confirming the supervising physician through NPI verification

Precision Biologics verifies every account against a National Provider Identifier in the NPPES registry. For a medspa, this generally means identifying the supervising or medical director physician whose license the account is tied to, rather than the aesthetician or injector performing a given service.

Shipping cryopreserved and shelf-stable formats

Cryopreserved Wharton's jelly formats ship overnight on dry ice in validated containers and are tracked by lot from release to delivery. Lyophilized formats, including the freeze-dried Wharton's jelly and exosome products, are shelf-stable and ship at ambient temperature with handling instructions supplied in the product insert.

We confirm a receiving contact at the Tallahassee location before any cryopreserved shipment is released so the shipment is not left unattended on arrival.

Licensure, medical director verification and account support

We ask every Florida medspa or dermatology account to verify the supervising physician's licensure directly with the Florida Board of Medicine or Board of Osteopathic Medicine, and to confirm with its own counsel how a specific product and intended use fit within federal tissue regulations.

These products are not FDA approved or licensed for any disease or condition; information provided to accounts is for licensed healthcare professionals and is not medical or legal advice. Our account team can arrange a physician-level call to review available documentation ahead of a purchasing decision.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.